Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-31

FDA Approved: RANOLAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ranolazine under Sun Pharmaceutical Industries’ ANDA211707. This approval updates the status of this generic product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

SUPPL AP for RANOLAZINE (RANOLAZINE)